Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets
- 1 October 2017
- journal article
- Published by Elsevier in Cancer Genetics
- Vol. 216-217, 37-51
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- SMOTE for high-dimensional class-imbalanced dataBMC Bioinformatics, 2013
- NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sinkNature Chemical Biology, 2013
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- Therapeutic Strategies for Targeting Ras ProteinsGenes & Cancer, 2011
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinomaMolecular Cancer, 2009
- CMA – a comprehensive Bioconductor package for supervised classification with high dimensional dataBMC Bioinformatics, 2008
- Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinomaBMC Cancer, 2008
- DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene listsNucleic Acids Research, 2007
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958